Recursion Pharmaceuticals, Inc. (RXRX)
4.17
+0.08
(+1.96%)
USD |
NASDAQ |
Jan 02, 10:53
Recursion Pharmaceuticals Research and Development Expense (TTM): 433.37M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Hims & Hers Health, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 344.78M |
| Amicus Therapeutics, Inc. | 142.29M |
| iBio, Inc. | 10.56M |
| GT Biopharma, Inc. | 4.026M |